Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.

Journal of drugs in dermatology : JDD

Volumn 6, Issue 6, 2007, Pages 641-645

  Fowler Jr , Joseph F ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE; METRONIDAZOLE;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; GEL; HUMAN; MALE; MICROCAPSULE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; ROSACEA; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CAPSULES; DELAYED-ACTION PREPARATIONS; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GELS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; NASOPHARYNGITIS; ROSACEA; TREATMENT OUTCOME;

EID: 34548404625     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)